Newest Guidance and Evidence for Health Care Providers: COVID-19 and Other Vaccines - 05/12/22
Doi : 10.1016/j.amjmed.2022.09.018
Alexandra Rubenstein, BA a, ⁎ 
, Sarah K. Wood, MD b, Vama Jhumkhawala, BS, MPH c, Mark J. DiCorcia, PhD d, Dennis G. Maki, MD e, Charles H. Hennekens, MD f
, Sarah K. Wood, MD b, Vama Jhumkhawala, BS, MPH c, Mark J. DiCorcia, PhD d, Dennis G. Maki, MD e, Charles H. Hennekens, MD f a Clinical Research Coordinator, Department of Neurology, Boston Medical Center, Boston, Mass
b Professor of Pediatrics and Interim Chair, Department of Women's & Children's Health, Vice Dean for Medical Education, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Fla
c M1 medical student, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Fla
d Associate Professor of Obstetrics and Gynecology, Assistant Dean for Medical Education, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Fla
e Ovid O. Meyer Professor of Medicine, and Director, COVID-19 Intensive Care Unit, University of Wisconsin School of Medicine and Public Health, Madison
f First Sir Richard Doll Professor of Medicine and Senior Academic Adviser to the Dean, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Fla
⁎Requests for reprints should be addressed to Alexandra Rubenstein, Clinical Research Coordinator, Department of Neurology, Boston Medical Center, One Boston Medical Center Place, Boston, MA, 02118.Clinical Research CoordinatorDepartment of NeurologyBoston Medical CenterOne Boston Medical Center PlaceBostonMA02118
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
| Funding: None. |
|
| Conflicts of Interest: AR, VJ, MJDC, and DGM report none. SKW reports that she serves as an independent scientist in an advisory role to investigators and sponsors as a member of a data monitoring committee for Amgen. CHH reports that he serves as an independent scientist in an advisory role to investigators and sponsors as chair of data monitoring committees for Amgen, British Heart Foundation, Cadila, Canadian Institutes of Health Research, and DalCor, to the Collaborative Institutional Training Initiative (CITI), the US Food and Drug Administration, and UpToDate; receives royalties for authorship or editorship of 3 textbooks and as coinventor on patents for inflammatory markers and cardiovascular disease that are held by Brigham and Women's Hospital; has an investment management relationship with the West-Bacon Group within Truist Investment Services, which has discretionary investment authority; does not own any common or preferred stock in any pharmaceutical or medical device company. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
© 2022
Elsevier Inc. Tous droits réservés.
Vol 136 - N° 1
P. 3-5 - janvier 2023 Retour au numéro
Article précédent
- Plus ça change, plus c'est la même chose* [The More Things Change, the More They Remain the Same.]
- Joseph S. Alpert
- Revisiting ACCORD: Should Blood Pressure Targets in People With and Without Type 2 Diabetes Be Different?
- Cindy Xinxin Du, Chenxi Huang, Yuan Lu, Erica S. Spatz, Kasia J. Lipska, Harlan M. Krumholz
Bienvenue sur EM-consulte, la référence des professionnels de santé.